
FDA Issues Guidance on Outsourcing Registration
The agency issues guidance for companies considering registering with FDA as an outsourcing facility.
FDA released
The FDA guidance gives more information about the regulatory impact of registering as an outsourcing facility, so companies may be better prepared to make the decision to register. FDA issued a separate guidance that details the process for registering.
Source:
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.